Loading...

Health Insurance Innovations

LSE:0J3U
Snowflake Description

Excellent balance sheet with reasonable growth potential.

The Snowflake is generated from 30 checks in 5 different areas, read more below.
0J3U
LSE
$364M
Imp Market Cap
  1. Home
  2. GB
  3. Insurance
Company description

Health Insurance Innovations, Inc. operates as a cloud-based technology platform and distributor of individual and family health insurance plans, and supplemental products in the United States. The last earnings update was 35 days ago. More info.


Add to Portfolio Compare Print
0J3U Share Price and Events
7 Day Returns
0%
LSE:0J3U
4.5%
GB Insurance
1%
GB Market
1 Year Returns
-7.7%
LSE:0J3U
-4.1%
GB Insurance
1.6%
GB Market
0J3U Shareholder Return
  7 Day 30 Day 90 Day 1 Year 3 Year 5 Year
Health Insurance Innovations (0J3U) 0% - - -7.7% - -
GB Insurance 4.5% 3.4% 13% -4.1% 14.6% 24.5%
GB Market 1% 2.3% 8.6% 1.6% 14% 5.9%
1 Year Return vs Industry and Market
  • 0J3U underperformed the Insurance industry which returned -4.1% over the past year.
  • 0J3U underperformed the Market in United Kingdom of Great Britain and Northern Ireland which returned 1.6% over the past year.
Price Volatility
0J3U
Industry
5yr Volatility vs Market

Value

 Is Health Insurance Innovations undervalued based on future cash flows and its price relative to the stock market?

Value is all about what a company is worth versus what price it is available for. If you went into a grocery store and all the bananas were on sale at half price, they could be considered undervalued.
INTRINSIC VALUE BASED ON FUTURE CASH FLOWS
Here we compare the current share price of Health Insurance Innovations to its discounted cash flow analysis.value.

The discounted cash flow value is simply looking at what the company is worth today, based on estimates of how much money it is expected to make in the future.
Raw Data

Below are the data sources, inputs and calculation used to determine the intrinsic value for Health Insurance Innovations.

LSE:0J3U Discounted Cash Flow Data Sources
Data Point Source Value
Valuation Model Excess Returns Model
Stable EPS Median Return on Equity from the past 5 years.
= Stable Book Value * Return on Equity
= $6.13 * 19.5%
$1.20
Book Value of Equity per Share Median Book Value from the past 5 years. $6.13
Discount Rate (Cost of Equity) See below 6.2%
Perpetual Growth Rate 10-Year GB Government Bond Rate 1.2%

An important part of a discounted cash flow is the discount rate, below we explain how it has been calculated.

Calculation of Discount Rate/ Cost of Equity for LSE:0J3U
Data Point Calculation/ Source Result
Risk-Free Rate 10-Year GB Govt Bond Rate 1.2%
Equity Risk Premium S&P Global 6%
Insurance Unlevered Beta Simply Wall St/ S&P Global 0.73
Re-levered Beta = Unlevered beta (1 + (1- tax rate) (Debt/Equity))
= 0.726 (1 + (1- 21%) (4.13%))
0.832
Levered Beta Levered Beta limited to 0.8 to 2.0
(practical range for a stable firm)
0.83
Discount Rate/ Cost of Equity = Cost of Equity = Risk Free Rate + (Levered Beta * Equity Risk Premium)
= 1.23% + (0.832 * 5.96%)
6.19%

Discounted Cash Flow Calculation for LSE:0J3U using Excess Returns Model Model

The calculations below outline how an intrinsic value for Health Insurance Innovations is arrived at using the Excess Return Model. This approach is used for finance firms where free cash flow is difficult to estimate.

In the Excess Return Model the value of a firm can be written as the sum of capital invested currently in the firm and the present value of excess returns that the firm expects to make in the future.

The model is sensitive to the Return on Equity of the company versus the Cost of Equity, how these are calculated is detailed below the main calculation.

Note the calculations below are per share.

See our documentation to learn about this calculation.

LSE:0J3U Value of Excess Returns
Calculation Result
Excess Returns = (Stable Return on equity – Cost of equity) (Book Value of Equity per share)
= (19.5% – 6.19%) * $6.13)
$0.82
Terminal Value of Excess Returns = Excess Returns / (Cost of Equity - Expected Growth Rate)
= $0.82 / (6.19% - 1.23%)
$16.45
Value of Equity = Book Value per share + Terminal Value of Excess Returns
= $6.13 + $16.45
$22.58
LSE:0J3U Discount to Share Price
Calculation Result
Non-primary Listing Adjustment Factor 1 share in LSE:0J3U represents 1.11237x of NasdaqGM:HIIQ
(This could be a different class, a depositary receipt, a different currency, or all of these things.)
1.11237x
Value per Share
(Listing Adjusted, USD)
= Value per Share (USD) x Listing Adjustment Factor
= $ 22.58 x 1.11237
$25.12
Value per share (USD) From above. $25.12
Current discount Discount to share price of $26.53
= -1 x ($26.53 - $25.12) / $25.12
-5.6%

Learn more about our DCF calculations in Simply Wall St’s analysis model .

  • The current share price of Health Insurance Innovations is above its future cash flow value.
Often investors are willing to pay a premium for a company that has a high dividend or the potential for future growth.
PRICE RELATIVE TO MARKET
We can also value a company based on what the stock market is willing to pay for it. This is similar to the price of fruit (e.g. Mangoes or Avocados) increasing when they are out of season, or how much your home is worth.

The amount the stock market is willing to pay for Health Insurance Innovations's earnings, growth and assets is considered below, and whether this is a fair price.
Price based on past earnings
Are Health Insurance Innovations's earnings available for a low price, and how does this compare to other companies in the same industry?
Raw Data
LSE:0J3U PE (Price to Earnings) Ratio Data Sources
Data Point Source Value
Earnings Per Share * Company Filings (2018-12-31) in USD $1.07
NasdaqGM:HIIQ Share Price ** NasdaqGM (2019-04-03) in USD $23.85
United Kingdom of Great Britain and Northern Ireland Insurance Industry PE Ratio Median Figure of 19 Publicly-Listed Insurance Companies 16x
United Kingdom of Great Britain and Northern Ireland Market PE Ratio Median Figure of 795 Publicly-Listed Companies 16.28x

* Trailing twelve months (TTM) annual GAAP earnings per share excluding extraordinary items.

** Primary Listing of Health Insurance Innovations.

LSE:0J3U PE (Price to Earnings) Ratio Calculation
Calculation Outcome
PE Ratio

= NasdaqGM:HIIQ Share Price ÷ EPS (both in USD)

= 23.85 ÷ 1.07

22.39x

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Health Insurance Innovations is overvalued based on earnings compared to the GB Insurance industry average.
  • Health Insurance Innovations is overvalued based on earnings compared to the United Kingdom of Great Britain and Northern Ireland market.
Price based on expected Growth
Does Health Insurance Innovations's expected growth come at a high price?
Raw Data
LSE:0J3U PEG (Price to Earnings to Growth) Ratio Data Sources
Data Point Source Value
PE Ratio See PE Ratio Section 22.39x
Net Income Annual Growth Rate See Future Growth Section.
Line of Best Fit* through Consensus Estimate Earnings of 7 Analysts
42.2%per year
United Kingdom of Great Britain and Northern Ireland Insurance Industry PEG Ratio Median Figure of 16 Publicly-Listed Insurance Companies 1.58x
United Kingdom of Great Britain and Northern Ireland Market PEG Ratio Median Figure of 563 Publicly-Listed Companies 1.49x

*Line of best fit is calculated by linear regression .

LSE:0J3U PEG (Price to Earnings to Growth) Ratio Calculation
Calculation Outcome
PEG Ratio

= PE Ratio ÷ Net Income Annual Growth Rate

= 22.39x ÷ 42.2%

0.53x

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Health Insurance Innovations is good value based on expected growth next year.
Price based on value of assets
What value do investors place on Health Insurance Innovations's assets?
Raw Data
LSE:0J3U PB (Price to Book) Ratio Data Sources
Data Point Source Value
Book Value per Share Company Filings (2018-12-31) in USD $8.70
NasdaqGM:HIIQ Share Price * NasdaqGM (2019-04-03) in USD $23.85
United Kingdom of Great Britain and Northern Ireland Insurance Industry PB Ratio Median Figure of 24 Publicly-Listed Insurance Companies 2.14x
United Kingdom of Great Britain and Northern Ireland Market PB Ratio Median Figure of 1,365 Publicly-Listed Companies 1.52x
LSE:0J3U PB (Price to Book) Ratio Calculation
Calculation Outcome
PB Ratio

= NasdaqGM:HIIQ Share Price ÷ Book Value per Share (both in USD)

= 23.85 ÷ 8.70

2.74x

* Primary Listing of Health Insurance Innovations.

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Health Insurance Innovations is overvalued based on assets compared to the GB Insurance industry average.
X
Value checks
We assess Health Insurance Innovations's value by looking at:
  1. Is the discounted cash flow value less than 20%, or 40% of the share price? (2 checks) ( Click here or on bar chart for details of DCF calculation. )
  2. Is the PE ratio less than the market average, and/ or less than the Insurance industry average (and greater than 0)? (2 checks)
  3. Is the PEG ratio within a reasonable range (0 to 1)? (1 check)
  4. Is the PB ratio less than the Insurance industry average (and greater than 0)? (1 check)
  5. Health Insurance Innovations has a total score of 1/6, see the detailed checks below.

    Note: We use GAAP Earnings per Share in all our calculations including PE and PEG Ratio.

    Full details on the Value part of the Simply Wall St company analysis model.

Future Performance

 How is Health Insurance Innovations expected to perform in the next 1 to 3 years based on estimates from 7 analysts?

The future performance of a company is measured in the same way as past performance, by looking at estimated growth and how much profit it is expected to make.

Future estimates come from professional analysts. Just like forecasting the weather, they don’t always get it right!
Annual Growth Rate
42.2%
Expected annual growth in earnings.
Earnings growth vs Low Risk Savings
Is Health Insurance Innovations expected to grow at an attractive rate?
  • Health Insurance Innovations's earnings growth is expected to exceed the low risk savings rate of 1.2%.
Growth vs Market Checks
  • Health Insurance Innovations's earnings growth is expected to exceed the United Kingdom of Great Britain and Northern Ireland market average.
  • Health Insurance Innovations's revenue growth is expected to exceed the United Kingdom of Great Britain and Northern Ireland market average.
Annual Growth Rates Comparison
Raw Data
LSE:0J3U Future Growth Rates Data Sources
Data Point Source Value (per year)
LSE:0J3U Future Earnings Growth Rate Line of Best Fit* through Consensus Estimate Earnings of 7 Analysts 42.2%
LSE:0J3U Future Revenue Growth Rate Line of Best Fit* through Consensus Estimate Revenue of 7 Analysts 11.3%
United Kingdom of Great Britain and Northern Ireland Insurance Industry Earnings Growth Rate Market Cap Weighted Average 11.7%
United Kingdom of Great Britain and Northern Ireland Insurance Industry Revenue Growth Rate Market Cap Weighted Average 18.3%
United Kingdom of Great Britain and Northern Ireland Market Earnings Growth Rate Market Cap Weighted Average 11.1%
United Kingdom of Great Britain and Northern Ireland Market Revenue Growth Rate Market Cap Weighted Average 4.8%

*Line of best fit is calculated by linear regression .

Industry and Market average data is calculated daily.

Learn more about our growth rate calculations in Simply Wall St’s analysis model.

Analysts growth expectations
Raw Data
LSE:0J3U Analysts Growth Expectations Data Sources
Data Point Source Value
Past Financials Company Filings (3 months ago) See Below
Future Estimates Average of up to 7 Analyst Estimates (S&P Global) See Below
All numbers in USD Millions and using Trailing twelve months (TTM) annual period rather than quarterly.
LSE:0J3U Future Estimates Data
Date (Data in USD Millions) Revenue Cash Flow Net Income * Avg. No. Analysts
2023-12-31 607 1
2022-12-31 578 1
2021-12-31 540 1
2020-12-31 495 33 5
2019-12-31 434 46 30 7
LSE:0J3U Past Financials Data
Date (Data in USD Millions) Revenue Cash Flow Net Income *
2018-12-31 351 22 13
2018-09-30 283 21 14
2018-06-30 272 35 15
2018-03-31 262 38 16
2017-12-31 250 45 18
2017-09-30 232 46 14
2017-06-30 215 44 12
2017-03-31 198 32 9
2016-12-31 185 23 5
2016-09-30 167 6 5
2016-06-30 146 -11 4
2016-03-31 125 -16 1

*GAAP earnings excluding extraordinary items.

Super high growth metrics
High Growth Checks
  • Health Insurance Innovations's earnings are expected to grow significantly at over 20% yearly.
  • Health Insurance Innovations's revenue is expected to grow by 11.3% yearly, however this is not considered high growth (20% yearly).
Past and Future Earnings per Share
The accuracy of the analysts who estimate the future performance data can be gauged below. We look back 3 years and see if they were any good at predicting what actually occurred. We also show the highest and lowest estimates looking forward to see if there is a wide range.
Raw Data
LSE:0J3U Past and Future Earnings per Share
Data Point Source Value
Past Financials Company Filings (3 months ago) See Below
Future Estimates Average of up to 7 Analyst Estimates (S&P Global) See Below

All data from Health Insurance Innovations Company Filings, last reported 3 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

LSE:0J3U Future Estimates Data
Date (Data in USD Millions) EPS * EPS High Estimate EPS Low Estimate Avg. No. Analysts
2023-12-31
2022-12-31
2021-12-31
2020-12-31 2.49 2.74 2.25 5.00
2019-12-31 2.12 2.74 1.90 6.00
LSE:0J3U Past Financials Data
Date (Data in USD Millions) EPS *
2018-12-31 1.07
2018-09-30 1.15
2018-06-30 1.25
2018-03-31 1.39
2017-12-31 1.63
2017-09-30 1.40
2017-06-30 1.34
2017-03-31 1.19
2016-12-31 0.59
2016-09-30 0.64
2016-06-30 0.48
2016-03-31 0.19

*GAAP earnings excluding extraordinary items.

Performance in 3 years
In the same way as past performance we look at the future estimated return (profit) compared to the available funds. We do this looking forward 3 years.
  • Unable to establish if Health Insurance Innovations will efficiently use shareholders’ funds in the future without estimates of Return on Equity.
X
Future performance checks
We assess Health Insurance Innovations's future performance by looking at:
  1. Is the annual earnings growth rate expected to beat the low risk savings rate, plus a premium to keep pace with inflation?
  2. Is the annual earnings growth rate expected to beat the average growth rate in earnings of the United Kingdom of Great Britain and Northern Ireland market? (1 check)
  3. Is the annual revenue growth rate expected to beat the average growth rate in revenue of the United Kingdom of Great Britain and Northern Ireland market? (1 check)
  4. Is the annual earnings growth rate expected to be above 20%? (1 check)
  5. Is the annual revenue growth rate expected to be above 20%? (1 check)
  6. Is the Return on Equity in 3 years expected to be over 20%? (1 check)
Some of the above checks will fail if the company is expected to be loss making in the relevant year.
Health Insurance Innovations has a total score of 4/6, see the detailed checks below.

Note 1: We use GAAP Net Income Excluding Exceptional Items for our Earnings in all our calculations.

Full details on the Future part of the Simply Wall St company analysis model.

Past Performance

  How has Health Insurance Innovations performed over the past 5 years?

The past performance of a company can be measured by how much growth it has experienced and how much profit it makes relative to the funds and assets it has available.
Past earnings growth
Below we compare Health Insurance Innovations's growth in the last year to its industry (Insurance).
Past Earnings growth analysis
We also check if the company has grown in the past 5 years, and whether it has maintained that growth in the year.
  • Health Insurance Innovations has delivered over 20% year on year earnings growth in the past 5 years.
  • Health Insurance Innovations's 1-year earnings growth is negative, it can't be compared to the 5-year average.
  • Health Insurance Innovations's 1-year earnings growth is negative, it can't be compared to the GB Insurance industry average.
Earnings and Revenue History
Health Insurance Innovations's revenue and profit over the past 5 years is shown below, any years where they have experienced a loss will show up in red.
Raw Data

All data from Health Insurance Innovations Company Filings, last reported 3 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

LSE:0J3U Past Revenue, Cash Flow and Net Income Data
Date (Data in USD Millions) Revenue Net Income * G+A Expenses R&D Expenses
2018-12-31 351.10 12.99 311.35
2018-09-30 282.98 13.84 247.66
2018-06-30 272.30 14.68 235.23
2018-03-31 262.36 16.20 224.24
2017-12-31 250.48 17.89 214.63
2017-09-30 232.41 13.91 197.04
2017-06-30 215.18 11.97 182.05
2017-03-31 197.89 9.44 169.16
2016-12-31 184.52 4.51 161.29
2016-09-30 166.71 4.84 145.97
2016-06-30 146.40 3.64 132.22
2016-03-31 124.65 1.45 115.93
2015-12-31 104.70 0.60 99.69
2015-09-30 97.62 0.53 93.39
2015-06-30 95.18 -0.81 92.03
2015-03-31 93.37 -0.21 89.25
2014-12-31 88.76 -0.34 83.93
2014-09-30 78.05 -0.08 75.59
2014-06-30 69.43 0.94 66.88
2014-03-31 62.10 0.26 61.62
2013-12-31 56.64 -3.36 57.08
2013-09-30 52.66 -2.98 52.17
2013-06-30 49.55 -2.46 48.05
2013-03-31 45.89 -1.16 42.67
2012-12-31 41.94 3.35 37.43
2012-09-30 38.19 1.34 33.79

*GAAP earnings excluding extraordinary items.

Performance last year
We want to ensure a company is making the most of what it has available. This is done by comparing the return (profit) to a company's available funds, assets and capital.
  • Health Insurance Innovations has not efficiently used shareholders’ funds last year (Return on Equity less than 20%).
  • Health Insurance Innovations used its assets more efficiently than the GB Insurance industry average last year based on Return on Assets.
  • Health Insurance Innovations has significantly improved its use of capital last year versus 3 years ago (Return on Capital Employed).
X
Past performance checks
We assess Health Insurance Innovations's performance over the past 5 years by checking for:
  1. Has earnings increased in past 5 years? (1 check)
  2. Has the earnings growth in the last year exceeded that of the Insurance industry? (1 check)
  3. Is the recent earnings growth over the last year higher than the average annual growth over the past 5 years? (1 check)
  4. Is the Return on Equity (ROE) higher than 20%? (1 check)
  5. Is the Return on Assets (ROA) above industry average? (1 check)
  6. Has the Return on Capital Employed (ROCE) increased from 3 years ago? (1 check)
The above checks will fail if the company has reported a loss in the most recent earnings report. Some checks require at least 3 or 5 years worth of data.
Health Insurance Innovations has a total score of 3/6, see the detailed checks below.

Note: We use GAAP Net Income excluding extraordinary items in all our calculations.

Full details on the Past part of the Simply Wall St company analysis model.

Health

 How is Health Insurance Innovations's financial health and their level of debt?

A company's financial position is much like your own financial position, it includes everything you own (assets) and owe (liabilities).

The boxes below represent the relative size of what makes up Health Insurance Innovations's finances.

The net worth of a company is the difference between its assets and liabilities.
Net Worth
  • Health Insurance Innovations is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
  • Health Insurance Innovations's cash and other short term assets cover its long term commitments.
Balance sheet
This treemap shows a more detailed breakdown of Health Insurance Innovations's finances. If any of them are yellow this indicates they may be out of proportion and red means they relate to one of the checks below.
Assets
Liabilities and shares
The 'shares' portion represents any funds contributed by the owners (shareholders) and any profits.
  • Low level of unsold assets.
  • Debt is covered by short term assets, assets are 14.9x debt.
Historical Debt
Nearly all companies have debt. Debt in itself isn’t bad, however if the debt is too high, or the company can’t afford to pay the interest on its debts this may have impacts in the future.

The graphic below shows equity (available funds) and debt, we ideally want to see the red area (debt) decreasing.

If there is any debt we look at the companies capability to repay it, and whether the level has increased over the past 5 years.
Raw Data

All data from Health Insurance Innovations Company Filings, last reported 3 months ago.

LSE:0J3U Past Debt and Equity Data
Date (Data in USD Millions) Total Equity Total Debt Cash & Short Term Investments
2018-12-31 143.47 15.00 9.32
2018-09-30 107.97 0.00 33.14
2018-06-30 118.01 0.00 49.22
2018-03-31 115.55 0.00 41.93
2017-12-31 107.00 0.00 40.91
2017-09-30 105.13 0.00 43.06
2017-06-30 97.52 0.00 27.53
2017-03-31 90.23 0.00 15.83
2016-12-31 80.08 0.00 12.21
2016-09-30 77.52 5.00 14.26
2016-06-30 75.49 14.00 9.27
2016-03-31 70.82 15.00 6.85
2015-12-31 68.05 7.50 7.70
2015-09-30 67.53 2.50 7.93
2015-06-30 65.85 0.00 8.81
2015-03-31 66.19 0.00 10.52
2014-12-31 66.71 0.00 16.45
2014-09-30 66.11 0.00 14.31
2014-06-30 59.14 0.00 35.47
2014-03-31 57.81 0.00 34.21
2013-12-31 57.78 0.00 23.93
2013-09-30 59.25 0.00 40.86
2013-06-30 57.58 0.01 48.47
2013-03-31 57.19 0.01 49.97
2012-12-31 6.34 3.29 0.75
2012-09-30 6.87 3.61 0.98
  • Health Insurance Innovations's level of debt (10.5%) compared to net worth is satisfactory (less than 40%).
  • The level of debt compared to net worth has increased over the past 5 years (0% vs 10.5% today).
  • Debt is well covered by operating cash flow (145.1%, greater than 20% of total debt).
  • Interest payments on debt are well covered by earnings (EBIT is 1398x coverage).
X
Financial health checks
We assess Health Insurance Innovations's financial health by checking for:
  1. Are short term assets greater than short term liabilities? (1 check)
  2. Are short term assets greater than long term liabilities? (1 check)
  3. Has the debt to equity ratio increased in the past 5 years? (1 check)
  4. Is the debt to equity ratio over 40%? (1 check)
  5. Is the debt covered by operating cash flow? (1 check)
  6. Are earnings greater than 5x the interest on debt (if company pays interest at all)? (1 check)
  7. Health Insurance Innovations has a total score of 5/6, see the detailed checks below.
For companies that are loss making and have been so on average in the past we replace the last 2 checks with:
  1. Does cash and short term investments cover stable operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)
  2. Does cash and short term investments cover growing operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)


Full details on the Health part of the Simply Wall St company analysis model.

Dividends

 What is Health Insurance Innovations's current dividend yield, its reliability and sustainability?

Dividends are regular cash payments to you from the company, similar to a bank paying you interest on a savings account.
Annual Dividend Income
Dividend payments
0%
Current annual income from Health Insurance Innovations dividends.
If you bought $2,000 of Health Insurance Innovations shares you are expected to receive $0 in your first year as a dividend.
Dividend Amount
Here we look how much dividend is being paid, if any. Is it above what you can get in a savings account? It is up there with the best dividend paying companies?
  • Unable to evaluate Health Insurance Innovations's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.
  • Unable to evaluate Health Insurance Innovations's dividend against the top 25% market benchmark as the company has not reported any payouts.
Annualized Historical and Future Dividends
It is important to see if the dividend for a company is stable, and not wildly increasing/decreasing each year. This graph shows you the historical rate to count toward your assessment of the stock.

We also check to see if the dividend has increased in the past 10 years.
Raw Data
LSE:0J3U Annualized Past and Future Dividends
Data Point Source Value
Past Annualized Dividend Yield S&P Global Market Data See Below
Past Dividends per Share Company Filings/ Annualized Dividend Payments See Below
Future Dividends per Share Estimates Average of up to 7 Analyst Estimates (S&P Global) See Below
United Kingdom of Great Britain and Northern Ireland Insurance Industry Average Dividend Yield Market Cap Weighted Average of 21 Stocks 4.5%
United Kingdom of Great Britain and Northern Ireland Market Average Dividend Yield Market Cap Weighted Average of 705 Stocks 4.2%
United Kingdom of Great Britain and Northern Ireland Minimum Threshold Dividend Yield 10th Percentile 1%
United Kingdom of Great Britain and Northern Ireland Bottom 25% Dividend Yield 25th Percentile 2%
United Kingdom of Great Britain and Northern Ireland Top 25% Dividend Yield 75th Percentile 5.1%

Industry and Market average data is calculated daily.

Note all dividend per share amounts are annualized and not quarterly or other period.

LSE:0J3U Future Dividends Estimate Data
Date (Data in $) Dividend per Share (annual) Avg. No. Analysts
2023-12-31
2022-12-31
2021-12-31
2020-12-31
2019-12-31

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Unable to perform a dividend volatility check as Health Insurance Innovations has not reported any payouts.
  • Unable to verify if Health Insurance Innovations's dividend has been increasing as the company has not reported any payouts.
Current Payout to shareholders
What portion of Health Insurance Innovations's earnings are paid to the shareholders as a dividend.
  • Unable to calculate sustainability of dividends as Health Insurance Innovations has not reported any payouts.
Future Payout to shareholders
  • Insufficient estimate data to determine if a dividend will be paid in 3 years and that it will be sustainable.
X
Income/ dividend checks
We assess Health Insurance Innovations's dividend by checking for:
  1. Firstly is the company paying a notable dividend (greater than 1%) - if not then the rest of the checks are ignored.
  2. Is current dividend yield above the bottom 25% of dividend payers? (1 check)
  3. Is current dividend yield above the top 25% of dividend payers? (1 check)
  4. Have they paid a dividend for 10 years, and during this period has the dividend been volatile (drop of more than 25%)? (1 check)
  5. If they have paid a dividend for 10 years has it increased in this time? (1 check)
  6. How sustainable is the dividend, can Health Insurance Innovations afford to pay it from its earnings today and in 3 years (Payout ratio less than 90%)? (2 checks)
  7. Health Insurance Innovations has a total score of 0/6, see the detailed checks below.


Full details on the Dividends part of the Simply Wall St company analysis model.

Management

 What is the CEO of Health Insurance Innovations's salary, the management and board of directors tenure and is there insider trading?

Management is one of the most important areas of a company. We look at unreasonable CEO compensation, how long the team and board of directors have been around for and insider trading.
CEO
Gavin Southwell
COMPENSATION $10,312,217
AGE 40
TENURE AS CEO 2.4 years
CEO Bio

Mr. Gavin Southwell has been Chief Executive Officer of Health Insurance Innovations, Inc. since November 15, 2016 and has been its President since July 2016. Mr. Southwell served as a Consultant of Health Insurance Innovations, Inc. since April 18, 2016 until August 24, 2016. Mr. Southwell served as the Chief Operations Officer of Cooper Gay Swett & Crawford from May 2009 to January 2016. He served as the Head of operations at Cooper Gay Swett & Crawford Limited since April 2012. Mr. Southwell served as the Risk Manager of Beazley plc from October 2007 to April 2009. During his time at Beazley, Mr. Southwell was responsible for risk management, preparation for the new capital requirements under Solvency II and leading the internal management committee responsible for delegated underwriting. Before joining CGSC in 2009, he worked in various insurance roles, for Beazley and Willis after starting his career at Credit Agricole. Mr. Southwell served as Director of Health Insurance Innovations, Inc. since November 15, 2016 until 2018. Mr. Southwell is a Chartered Accountant. Mr. Southwell has detailed knowledge and extensive insurance background, including having worked in senior executive positions for a broker, MGU, insurer and reinsurer.

CEO Compensation
  • Gavin's compensation has increased by more than 20% whilst company earnings have fallen more than 20% in the past year.
  • Gavin's remuneration is higher than average for companies of similar size in United Kingdom of Great Britain and Northern Ireland.
Management Team Tenure

Average tenure and age of the Health Insurance Innovations management team in years:

3.3
Average Tenure
53.5
Average Age
  • The tenure for the Health Insurance Innovations management team is about average.
Management Team

Gavin Southwell

TITLE
President
COMPENSATION
$10M
AGE
40
TENURE
2.4 yrs

Mike Hershberger

TITLE
CFO, Treasurer & Secretary
COMPENSATION
$2M
AGE
55
TENURE
4.1 yrs

Mike Kosloske

TITLE
Founder & Director
COMPENSATION
$2M
AGE
54

John Evans

TITLE
Investor Relations contact
TENURE
3.3 yrs

Angela Bryant

TITLE
Senior VP & General Counsel

Gerod Vernon

TITLE
Vice President of Sales

Mike DeVries

TITLE
Senior Vice President of Finance

Jennifer Hammer

TITLE
Head of Strategic Initiatives Team
TENURE
0.3 yrs

Jeffrey Eisenberg

TITLE
Consultant
COMPENSATION
$10K
AGE
53
TENURE
4.5 yrs
Board of Directors Tenure

Average tenure and age of the Health Insurance Innovations board of directors in years:

3.5
Average Tenure
54
Average Age
  • The tenure for the Health Insurance Innovations board of directors is about average.
Board of Directors

Paul Gabos

TITLE
Non-Executive Chairman
COMPENSATION
$166K
AGE
52
TENURE
2.4 yrs

Gavin Southwell

TITLE
President
COMPENSATION
$10M
AGE
40
TENURE
2.4 yrs

Mike Kosloske

TITLE
Founder & Director
COMPENSATION
$2M
AGE
54

Anthony Barkett

TITLE
Director
COMPENSATION
$137K
AGE
71
TENURE
6.1 yrs

Bob Murley

TITLE
Director
COMPENSATION
$124K
AGE
68
TENURE
4.5 yrs

Paul Avery

TITLE
Director
COMPENSATION
$124K
AGE
58
TENURE
6.2 yrs

John Fichthorn

TITLE
Director
AGE
45
TENURE
1.3 yrs
Who owns this company?
Recent Insider Trading
  • More shares have been bought than sold by Health Insurance Innovations insiders in the past 3 months.
Recent Insider Transactions
Announced Type Name Entity Role Start End Shares Max Price ($) Value ($)
10. Apr 19 Buy Paul Gabos Individual 17. Dec 18 17. Dec 18 15,000 $30.63 $459,519
25. Mar 19 Buy Paul Avery Individual 20. Mar 19 20. Mar 19 3,000 $29.69 $89,061
20. Mar 19 Buy B. Riley Capital Management, LLC Company 20. Mar 19 20. Mar 19 90,742 $29.27 $2,655,664
20. Mar 19 Buy John Fichthorn Individual 20. Mar 19 20. Mar 19 3,000 $29.84 $89,513
20. Mar 19 Buy Paul Gabos Individual 20. Mar 19 20. Mar 19 8,000 $29.91 $239,254
27. Dec 18 Sell Cannell Capital LLC Company 02. Nov 18 13. Dec 18 -103,119 $49.21 $-5,074,816
27. Dec 18 Buy Cannell Capital LLC Company 02. Nov 18 26. Dec 18 386,197 $45.95 $17,746,216
18. Dec 18 Buy Robert Murley Individual 17. Dec 18 17. Dec 18 6,500 $30.85 $200,510
04. Sep 18 Sell Paul Avery Individual 01. Aug 18 01. Aug 18 -4,000 $37.00 $-148,000
18. Jun 18 Sell Dialectic Capital Management, LLC Company 15. Jun 18 19. Jun 18 -112,800 $34.98 $-3,878,806
18. Jun 18 Buy Dialectic Capital Management, LLC Company 19. Jun 18 19. Jun 18 11,162 $33.95 $378,919
14. May 18 Buy P2 Capital Partners, LLC Company 03. May 18 07. May 18 333,730 $27.84 $8,871,788
08. May 18 Buy John Fichthorn Individual 04. May 18 04. May 18 5,000 $26.65 $133,223
08. May 18 Buy Anthony Barkett Individual 08. May 18 08. May 18 3,597 $27.65 $99,439
X
Management checks
We assess Health Insurance Innovations's management by checking for:
  1. Is the CEO's compensation unreasonable compared to market cap? (1 check)
  2. Has the CEO's compensation increased more than 20% whilst the EPS is down more then 20%? (1 check)
  3. Is the average tenure of the management team less than 2 years? (1 check)
  4. Is the average tenure of the board of directors team less than 3 years? (1 check)
  5. Health Insurance Innovations has a total score of 0/6, this is not included on the snowflake, see the detailed checks below.


Note: We use the top 6 management executives and board members in our calculations.

Note 2: Insider trading include any internal stakeholders and these transactions .

Full details on the Management part of the Simply Wall St company analysis model.

News

Simply Wall St News

Company Info

Description

Health Insurance Innovations, Inc. operates as a cloud-based technology platform and distributor of individual and family health insurance plans, and supplemental products in the United States. It offers short-term medical plans that provide 3 months to 12 months of health insurance coverage with various deductible and copay levels; health benefit insurance plans, which offer fixed cash benefits and additional benefits for procedures and services; and supplemental insurance products, including life insurance policies, dental plans, vision plans, cancer/critical illness plans, deductible and gap protection plans, and pharmacy benefit cards. The company offers individual and family health insurance plans, and supplemental products in concert with insurance carriers and discount benefit providers; and markets them to individuals through a network of distributors. Health Insurance Innovations, Inc. was founded in 2008 and is based in Tampa, Florida.

Details
Name: Health Insurance Innovations, Inc.
0J3U
Exchange: LSE
Founded: 2008
$363,537,433
$301,400,773
15,179,016
Website: http://www.hiiq.com
Address: Health Insurance Innovations, Inc.
15438 North Florida Avenue,
Suite 201,
Tampa,
Florida, 33613,
United States
Listings
Exchange Symbol Ticker Symbol Security Exchange Country Currency Listed on
NasdaqGM HIIQ Class A Common Stock Nasdaq Global Market US USD 11. Feb 2013
DB 6LN Class A Common Stock Deutsche Boerse AG DE EUR 11. Feb 2013
LSE 0J3U Class A Common Stock London Stock Exchange GB USD 11. Feb 2013
Number of employees
Current staff
Staff numbers
222
Health Insurance Innovations employees.
Industry
Insurance Brokers
Insurance
Company Analysis and Financial Data Status
Area Date (UTC time)
Company Analysis updated: 2019/04/18 22:45
End of day share price update: 2019/04/03 00:00
Last estimates confirmation: 2019/04/12
Last earnings filing: 2019/03/14
Last earnings reported: 2018/12/31
Last annual earnings reported: 2018/12/31


All dates and times in UTC. All financial data provided by Standard & Poor’s Capital IQ.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.